r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline (Q24806325)

scientific article

Language	Label	Description	Also known as
English	r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline	scientific article

Statements

instance of

scholarly article

0 references

title

r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline (English)

0 references

1 reference

Mihály Tapolyai

1

0 references

Satoshi Kadomatsu

series ordinal

2

0 references

Manuel Perera-Chong

series ordinal

3

0 references

language of work or name

English

0 references

publication date

17 June 2003

0 references

published in

BMC Nephrology

0 references

volume

4

0 references

issue

1

0 references

page(s)

3

0 references

cites work

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

28 September 2017

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

28 September 2017

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

28 September 2017

A simple method of estimating progression of chronic renal failure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

28 September 2017

Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

30 May 2018

Chronic progressive renal disease: rate of change of serum creatinine concentration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=165597

retrieved

30 May 2018

Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

Effect of recombinant human erythropoietin on renal function in humans

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

Renal function in predialysis children with chronic renal failure treated with erythropoietin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2369-4-3

retrieved

21 January 2018

Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12809563

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2369-4-3

0 references

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2369-4-3

PMC publication ID

165597

0 references

PubMed publication ID

12809563

0 references

ResearchGate publication ID

10704939

0 references

r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline (Q24806325)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline (Q24806325)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search